Vigabatrin May Help Prevent Seizures in TSC Children

Source: Seizure

Summary

Researchers studied the use of vigabatrin (VGB) as a preventive treatment for infants with tuberous sclerosis complex (TSC), a condition that often leads to early-onset epilepsy. The study included three separate research projects involving a total of 149 children who had TSC but had not yet experienced seizures. The goal was to see if VGB could help reduce the occurrence of seizures and improve cognitive outcomes compared to standard treatments.

The findings showed that children who received preventive VGB therapy had fewer seizures compared to those who did not, but the differences were not statistically significant. This means that while there was a trend suggesting VGB might be helpful, the results were not strong enough to confirm its effectiveness definitively. Additionally, there were no significant differences in cognitive outcomes between the two groups, and VGB was generally well-tolerated with few side effects.

This research is important because it suggests that early treatment with VGB could potentially help prevent epilepsy in children with TSC, which could lead to better long-term outcomes. However, since the results were not statistically significant, more extensive and higher-quality studies are needed to confirm these findings and understand the long-term effects of VGB on brain development.

Original source